Digoxin-Associated Visual Disturbances

Primary Visual Manifestations

The American Heart Association notes that blurred or yellow vision (xanthopsia) is the most characteristic visual disturbance, occurring as a classic sign of digoxin toxicity 2, 1
Visual disturbances are explicitly listed as one of the three major categories of digoxin adverse effects alongside cardiac arrhythmias and gastrointestinal symptoms 2

Overt visual toxicity is commonly associated with serum digoxin levels greater than 2 ng/mL 2, 1
Advanced age (>70 years) significantly increases susceptibility to visual side effects 3, 1
Hypokalemia, hypomagnesemia, and hypothyroidism potentiate visual toxicity even at lower serum levels 2, 1
Renal impairment elevates serum digoxin levels and increases risk of all adverse effects including visual disturbances 2, 1
Drug interactions with clarithromycin, erythromycin, amiodarone, itraconazole, cyclosporine, verapamil, or quinidine increase digoxin levels and toxicity risk 2, 1

The European Heart Journal recommends using lower doses (0.125 mg daily or every other day) in patients over 70 years, those with renal impairment, or low lean body mass 3, 1
Target serum concentrations of 0.5-0.9 ng/mL for heart failure to minimize toxicity risk 1
Reduce digoxin dose by 25-50% when initiating interacting medications like amiodarone or macrolide antibiotics 1
Monitor serum digoxin levels regularly in high-risk patients, particularly elderly individuals with multiple risk factors 1